We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1301:TWSEFormosa Plastics Corporation Analysis

Data as of 2026-03-11 - not real-time

NT$47.15

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Formosa Plastics trades at TWD 47.15, comfortably above its 20‑day (≈47.7) and 50‑day (≈44.4) simple moving averages, indicating a short‑term bullish bias. However, the MACD histogram is negative and the MACD line sits below its signal line, signaling bearish momentum, while the RSI hovers around the midpoint (≈50), suggesting no clear over‑bought or over‑sold condition. The stock sits near a technical support level around TWD 43.7 with a sizable resistance ceiling near TWD 54.8, and recent volume trends are increasing amid a high 30‑day volatility of roughly 65%, though its beta is modest (~0.5), implying limited market‑wide risk exposure.
Fundamentally, the company faces significant headwinds: revenue has contracted by about 18% year‑over‑year, margins are deeply negative (gross margin ~3%, operating margin ~‑6%), and ROE is in the negative range. The balance sheet shows a debt load that nearly equals cash, yielding a debt‑to‑equity ratio over 30, while free cash flow remains modest. A discounted cash flow model pins a fair value near TWD 10, far below the current price, and the forward PE of over 30 underscores an overvalued stance. The modest dividend yield (≈1%) is not backed by earnings, raising concerns about dividend sustainability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term SMAs supports bullish bias
  • Bearish MACD divergence warns of potential pullback
  • High volatility may amplify short‑term price swings

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Negative earnings trends and deteriorating margins
  • Elevated debt level relative to cash reserves
  • DCF fair‑value gap indicating limited upside

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Sustained revenue decline and negative profitability
  • Overvalued market price versus intrinsic valuation
  • Uncertain dividend sustainability amid weak earnings

Key Metrics & Analysis

Financial Health

Revenue Growth-18.30%
Profit Margin-5.73%
P/E Ratio31.8
ROE-3.08%
ROA-0.89%
Debt/Equity33.09
P/B Ratio0.8
Op. Cash FlowNT$6.6B
Free Cash FlowNT$4.7B

Technical Analysis

TrendBullish
RSI50.2
SupportNT$43.70
ResistanceNT$54.80
MA 20NT$47.72
MA 50NT$44.43
MA 200NT$39.74
MACDBearish
VolumeIncreasing
Fear & Greed Index75.64

Valuation

Fair ValueNT$10.10
Target PriceNT$46.33
Upside/Downside-1.73%
GradeOvervalued
TypeValue
Dividend Yield1.08%

Risk Assessment

Beta0.54
Volatility65.34%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.